Literature DB >> 2651126

The high-affinity binding of laminin to cells. Assignation of a major cell-binding site to the long arm of laminin and of a latent cell-binding site to its short arms.

V Nurcombe1, M Aumailley, R Timpl, D Edgar.   

Abstract

The laminin proteolytic fragments 1 (derived from the intersection of the short arms of the cruciform laminin molecule) and 8 (derived from the laminin long arm) bind to distinct receptors on HT-1080 human fibrosarcoma cells; both fragments are shown here to inhibit the high-affinity binding of laminin to these cells. Inhibition of binding between fragment 8 and laminin was competitive, whereas that between fragment 1 and laminin was noncompetitive. This indicates that laminin and fragment 8 most probably share the same cellular receptors, whereas laminin and fragment 1 bind to distinct receptors, inhibition being due to steric hindrance. Surprisingly, fragment 1-4 (corresponding to the complete short arms of laminin) neither bound to HT-1080 cells nor inhibited the binding of laminin or fragment 1. After treatment of fragment 1-4 with pepsin, however, the smaller subfragment 1 was liberated, which could then bind to the cells, and so was shown to block the binding of laminin and fragment 1. We conclude that native laminin bound to HT-1080 cells via the fragment-8-binding site near the end of its long arm. Although these cells also have distinct receptors for the short arm fragment 1, this receptor-binding site was not used as it appeared to be latent within the native laminin molecule.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2651126     DOI: 10.1111/j.1432-1033.1989.tb14608.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  14 in total

Review 1.  The role of laminin in attachment, growth, and differentiation of cultured cells: a brief review.

Authors:  M Paulsson
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

Review 2.  The role of laminins in basement membrane function.

Authors:  M Aumailley; N Smyth
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

Review 3.  The laminin family.

Authors:  Monique Aumailley
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

4.  Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms.

Authors:  G O Delwel; A A de Melker; F Hogervorst; L H Jaspars; D L Fles; I Kuikman; A Lindblom; M Paulsson; R Timpl; A Sonnenberg
Journal:  Mol Biol Cell       Date:  1994-02       Impact factor: 4.138

5.  Primary structure of the human laminin A chain. Limited expression in human tissues.

Authors:  M Nissinen; R Vuolteenaho; R Boot-Handford; P Kallunki; K Tryggvason
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

6.  A CHARMM analysis of the conformations of the metastasis-inhibiting laminin pentapeptide.

Authors:  D R McKelvey; C L Brooks; M Mokotoff
Journal:  J Protein Chem       Date:  1991-06

7.  Kalinin is more efficient than laminin in promoting adhesion of primary keratinocytes and some other epithelial cells and has a different requirement for integrin receptors.

Authors:  P Rousselle; M Aumailley
Journal:  J Cell Biol       Date:  1994-04       Impact factor: 10.539

8.  Multiple cell surface receptors for the short arms of laminin: alpha 1 beta 1 integrin and RGD-dependent proteins mediate cell attachment only to domains III in murine tumor laminin.

Authors:  S L Goodman; M Aumailley; H von der Mark
Journal:  J Cell Biol       Date:  1991-05       Impact factor: 10.539

9.  The integrin alpha 6 beta 4 is a laminin receptor.

Authors:  E C Lee; M M Lotz; G D Steele; A M Mercurio
Journal:  J Cell Biol       Date:  1992-05       Impact factor: 10.539

10.  Antibodies against domain E3 of laminin-1 and integrin alpha 6 subunit perturb branching epithelial morphogenesis of submandibular gland, but by different modes.

Authors:  Y Kadoya; K Kadoya; M Durbeej; K Holmvall; L Sorokin; P Ekblom
Journal:  J Cell Biol       Date:  1995-04       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.